These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15974986)

  • 1. Advances in the treatment of autoimmune diseases; cellular activity, type-1/type-2 cytokine secretion patterns and their modulation by therapeutic peptides.
    Mouzaki A; Deraos S; Chatzantoni K
    Curr Med Chem; 2005; 12(13):1537-50. PubMed ID: 15974986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-TNF-alpha antibody therapies in autoimmune diseases.
    Chatzantoni K; Mouzaki A
    Curr Top Med Chem; 2006; 6(16):1707-14. PubMed ID: 17017952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy in autoimmune diseases.
    Fong KY
    Ann Acad Med Singap; 2002 Nov; 31(6):702-6. PubMed ID: 12520821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The current outlook in the therapy of autoimmune diseases].
    Sebastiani GD; Passiu G
    Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine inhibitors in autoimmune disease.
    Weckmann AL; Alcocer-Varela J
    Semin Arthritis Rheum; 1996 Oct; 26(2):539-57. PubMed ID: 8916298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine patterns and pathogenicity in autoimmune diseases.
    Matei I; Matei L
    Rom J Intern Med; 2002; 40(1-4):27-41. PubMed ID: 15526538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An imbalance between Th1 and Th2-like cytokines in patients with autoimmune diseases--differential diagnosis between Th1 dominant autoimmune diseases and Th2 dominant autoimmune diseases].
    Ishida H; Ota H; Yanagida H; Dobashi H
    Nihon Rinsho; 1997 Jun; 55(6):1438-43. PubMed ID: 9200929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate lymphoid cell-derived cytokines in autoimmune diseases.
    Li S; Yang D; Peng T; Wu Y; Tian Z; Ni B
    J Autoimmun; 2017 Sep; 83():62-72. PubMed ID: 28479212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of central nervous system immune-mediated diseases: therapeutic interventions with bioactive peptides and mimetics.
    Grigoriadis N; Tselios T; Deraos S; Orologas A; Deraos G; Matsoukas J; Mavromatis I; Milonas I
    Curr Med Chem; 2005; 12(13):1513-9. PubMed ID: 15974984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.
    Cook AD; Visvanathan K
    Expert Opin Ther Targets; 2004 Oct; 8(5):375-90. PubMed ID: 15469389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

  • 13. Is pregnancy a model how we should control some autoimmune diseases?
    Draca S
    Autoimmunity; 2002 Aug; 35(5):307-12. PubMed ID: 12515284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the role of a possible dialogue between cytokine and TCR-presentation mechanisms in the regulation of autoimmune disease.
    Bar-Or RL; Segel LA
    J Theor Biol; 1998 Jan; 190(2):161-78. PubMed ID: 9538464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy in non-allergic diseases].
    Español T
    Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune modulation by plasmid DNA-mediated cytokine gene transfer.
    Piccirillo CA; Prud'homme GJ
    Curr Pharm Des; 2003; 9(1):83-94. PubMed ID: 12570678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
    Kidd P
    Altern Med Rev; 2003 Aug; 8(3):223-46. PubMed ID: 12946237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
    Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials.
    Deng Y; Wang Z; Chang C; Lu L; Lau CS; Lu Q
    Hum Immunol; 2017 Feb; 78(2):120-128. PubMed ID: 28040536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances and current state of immunotherapy in systemic lupus erythematosus.
    Mok MY; Shoenfeld Y
    Expert Opin Biol Ther; 2016 Jul; 16(7):927-39. PubMed ID: 27032059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.